Filing Flows › Procept BioRobotics (PRCT) › Guidance history
Procept BioRobotics (PRCT) guidance history: what it guided and what it reported
Procept BioRobotics gave guidance in 3 earnings releases on file since Apr 29, 2026.
Revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $390M–$410M (Apr 29, 2026) → reaffirmed $390M–$410M (Aug 4, 2026) → reaffirmed $390M–$410M (Nov 4, 2026) | — | to be reported | — |
Gross margin
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 65.0% (Apr 29, 2026) → reaffirmed 65.0% (Aug 4, 2026) → reaffirmed 65.0% (Nov 4, 2026) | — | to be reported | — |
Adjusted EBITDA
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $17.0M–$30.0M (Apr 29, 2026) → raised $30.0M–$35.0M (Aug 4, 2026) → reaffirmed $30.0M–$35.0M (Nov 4, 2026) | — | to be reported | — |
The latest quarter
Procept BioRobotics, Q3 2026: revenue $98.3M (+18% year over year), operating margin -27.9%, net loss $26.5M, operating cash flow −$9.0M. The chart follows the revenue to costs, profit and cash.
Questions
Does Procept BioRobotics beat its guidance?
Procept BioRobotics gave guidance in 3 earnings releases on file since Apr 29, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.